Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 231 followers
Latest posts
Last updated 2 days ago
Human medicines European public assessment report (EPAR): Xelevia, sitagliptin, Date of authorisation: 21/03/2007, Revision: 40, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Xelevia, sitagliptin, Date of authorisation...
Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation: 16/07/2008, Revision: 38, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation...
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 8, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion
Summary of opinion: Kisqali, 17/10/2024 Positive
2 days ago
Summary of opinion: Kisqali, 17/10/2024 Positive
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Status: Opinion
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Status: Opinion
Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Status: Opinion
Human medicines European public assessment report (EPAR): Masitinib AB Science, masitinib, Date of refusal: 17/10/2024, Status: Refused
2 days ago
Human medicines European public assessment report (EPAR): Masitinib AB Science, masitinib, Date...
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Zytiga, abiraterone, Date of authorisation: 05/09/2011, Revision: 28, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Zytiga, abiraterone, Date of authorisation...
Human medicines European public assessment report (EPAR): Velcade, bortezomib, Date of authorisation: 26/04/2004, Revision: 46, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Velcade, bortezomib, Date of authorisation...